Microcystic adnexal carcinoma – How to detect and treat? A rare tumor entity with challenging diagnosis and limited therapeutic options
Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S205-S206
DOI: 10.1055/s-0044-1784664 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Merete Hartmann und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Microcystic adnexal carcinomas (MAC) are rare, low-malignant tumors of the skin, characterized by locally invasive and destructive growth with high recurrence rate. However, lymphogenous or hematogenous metastasis are rarely described. MAC are tumors of the eccrine/apocrine sweat glands, occurring in the skin of the head and neck. MAC were initially described by the US-American dermatologist D.Goldstein, presenting 6 case reports of patients with slowly growing skin lesions with clinical benign features and destructive local growth pattern. Since then, around 200 cases of this rare carcinoma have been published in literature. Case report A 43-year-old male patient presented in 06/2021 with a skin-colored plaque with telangiectasia on the left preauricular side. An open surgical biopsy of the mass detected a MAC. The cMRI imaging showed diffuse infiltrative growth around the ear helix, the parotid gland and the left pterygopalatine fossa. Radical parotidectomy, ablatio auris and neck dissection on the left and defect repair using a supraclavicular islet graft was performed, stage: pT4 pN0 (0/16) M0 L0 Pn1 R0, close margin. Follow-up with cMRI imaging every 6 months continued. The cMRI 08/2023 showed a contrast uptake in the left pterygoid muscle, a new biopsy revealed a recurrence of the MAC.
Discussion
MAC pose a challenge to the clinician due to their unspecific presentation and late diagnosis. As there are still no specific treatment guidelines due to the low number of cases, surgical treatment has remained the standard of care since MAC were first described in 1982. In the future, experience with radiotherapy, chemotherapy and targeted immunotherapy approaches for locally advanced or metastatic tumors must be gathered to enable individualized therapy. Publication History Article published online: 19 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Hartmann, M., Beutner, D., & Meyer, A. (2024). Microcystic adnexal carcinoma – How to detect and treat? A rare tumor entity with challenging diagnosis and limited therapeutic options. Laryngo-Rhino-Otologie, 103(S 02 S 02), S205-S206. https://doi.org/10.1055/s-0044-1784664
Vancouver
Hartmann M, Beutner D, Meyer A. Microcystic adnexal carcinoma – How to detect and treat? A rare tumor entity with challenging diagnosis and limited therapeutic options. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S205-S206. doi:10.1055/s-0044-1784664
BibTeX
@article{Hartmann2024,
author = {Hartmann, Merete and Beutner, Dirk and Meyer, Alexander},
title = {Microcystic adnexal carcinoma – How to detect and treat? A rare tumor entity with challenging diagnosis and limited therapeutic options},
journal = {Laryngo-Rhino-Otologie},
year = {2024},
volume = {103},
number = {S 02 S 02},
pages = {S205--S206},
doi = {10.1055/s-0044-1784664}
}
EUVIMED